Vimarsana
Biggest News Aggregation in the World

Page 9 - Breakthrough Therapy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Breakthrough Therapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Breakthrough Therapy Today - Breaking & Trending Today

Ingrezza Sprinkle Capsules Received FDA Approval for Tardive Dyskinesia in Adults - Vimarsana News

Ingrezza Sprinkle Capsules Received FDA Approval for Tardive Dyskinesia in Adults

The new formulation was approved to help patients with tardive dyskinesia who have trouble swallowing.

Bavarian Nordic Initiates Rolling Submission of Biologics License Application with FDA for its Chikungunya Vaccine Candidate - Vimarsana News

Bavarian Nordic Initiates Rolling Submission of Biologics License Application with FDA for its Chikungunya Vaccine Candidate

COPENHAGEN, Denmark, April 29, 2024 – Bavarian Nordic A/S today announced that it has initiated the rolling submission process with the U.S. Food and Drug Administration for a Biologics License...

Compass Pathways and Journey Clinical establish research collaboration agreement to inform the training of healthcare providers and delivery model for COMP360 psilocybin treatment, if approved for treatment-resistant depression - Vimarsana News

Compass Pathways and Journey Clinical establish research collaboration agreement to inform the training of healthcare providers and delivery model for COMP360 psilocybin treatment, if approved for treatment-resistant depression

LONDON, April 29, 2024 -- Compass Pathways plc , a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, and Journey Clinical, a leading...

Renibus Therapeutics Announces Oral Presentations on RBT-1 at AATS and SCA Medical Conferences - Vimarsana News

Renibus Therapeutics Announces Oral Presentations on RBT-1 at AATS and SCA Medical Conferences

/PRNewswire/ -- Renibus Therapeutics® ("Renibus"), a clinical-stage biopharmaceutical company focusing on the prevention and treatment of cardio, renal and...

Ensysce Biosciences' CEO Dr. Lynn Kirkpatrick Featured in Xtalks Clinical ... 2024-04-25 - Vimarsana News

Ensysce Biosciences' CEO Dr. Lynn Kirkpatrick Featured in Xtalks Clinical ... 2024-04-25

Ensysce Biosciences’ CEO Dr. Lynn Kirkpatrick Featured in Xtalks Clinical ...